secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLIFE SOLUTIONS INC (BLFS)
CIK:        0000834365
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001628280-24-046909
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioLife Solutions sells SciSafe for $73M cash; closes Nov 12, 2024
------------------------------------------------------------------

- Sold all SciSafe shares to Subzero Purchaser Corp. for $73M; repaid $0.9M of SciSafe debt and paid $3.3M to waive earn-out rights.
- Entered transition services agreement with SciSafe for up to 6 months post-close.
- Amended SVB loan agreement; added $750K non-refundable termination fee upon early loan termination.
- Amended bylaws: quorum reduced to one-third voting power; added exclusive forum for derivative/Securities Act claims.
- Pro forma shows continuing ops net income of $9.5M for H1 2024 vs. historical loss of $11.4M; net loss per share improved to $(0.22).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/834365/000162828024046909/0001628280-24-046909-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/834365/000162828024046909/blfs-20241112.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-046909

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer